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lations (p < 0.05) were found between the MSLQ measurement
and the number of hours college students spent with friends,
studying, class missed, as well as the number of extra-curricular
activities and alcohol consumed. The SAS-SR measurement, on
the other hand, were signiﬁcantly correlated (p < 0.05) with only
the number of hours college students spent with friends and class
missed. CONCLUSION: The MSLQ is a better indicator of
student productivity in college than the SAS-SR. This is because
the SAS-SR, which was originally developed to evaluate
employee productivity, measures functional items that may be
too sensitive for student-related activities. The MSLQ was
designed to measure students’ study strategies.
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OBJECTIVES: This analysis was conducted as part of a feder-
ally funded national pilot to evaluate electronic prescribing in
the community practice setting. The objective was to measure
the incidence and nature of prescribing errors on e-prescriptions
that required active intervention by dispensing pharmacists to
correct. METHODS: A panel of participating pharmacists
reported their Medication Therapy Interventions (MTI) using a
standardized documentation protocol. RESULTS: Data were
reported from 68 participating chain pharmacies in 5 states
during 312 work shifts between July and September, 2006.
During the study pharmacists reviewed 2,690 e-prescription
orders (new = 83.0%, reﬁll = 17.0%) and intervened 102 times
for an intervention rate of 3.8%. The rate at which pharmacists
identiﬁed problems on new e-Rxs was found to be nearly twice
that of reﬁlls (4.1% and 2.2%, respectively). The most common
reason for pharmacists’ interventions on e-prescriptions was to
supplement omitted information (31.9%), especially missing
directions. Dosing errors were also quite common (17.7%). The
most common response by pharmacists to e-Rx problems was to
contact the prescriber (64.1%), consult the patient’s proﬁle or
medication history (12.8%), and/or interview the patient or the
patient’s representative (9.4%). In most cases (56%), the e-Rx
order was changed and the prescription was ultimately dis-
pensed. In 15% of cases the e-Rx order was dispensed as written
following clariﬁcation by the prescriber. In 10% of cases the pre-
scription was not dispensed. An additional 12% of prescription
issues remained unresolved. Pharmacists required an average of
6.07 minutes to conduct their interventions on problematic e-
prescription orders, representing an incremental dispensing cost
of $4.74. CONCLUSION: Electronic prescribing has the poten-
tial to improve the safety and efﬁciency of patient care. However,
as currently implemented in the community practice setting, it
maintains selected threats to both. Best practice recommenda-
tions are offered to improve the implementation of this impor-
tant technology.
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OBJECTIVES: Drug-drug interactions (DDIs) are preventable
medical errors, yet exposure to DDIs continues despite systems
designed to prevent such exposures. The purpose of this study
was to examine pharmacy characteristics that may be associated
with dispensed potential DDIs. METHODS: This study com-
bined survey data from community pharmacies in 18 metropol-
itan statistical areas with pharmacy claims submitted to 4
pharmacy beneﬁt managers (PBM) over a 3 month period from
January 1 to March 31, 2003. Pharmacy characteristics of inter-
est included prescription volume, the number of full-time equiv-
alent pharmacist and pharmacy staff, computer software
programs and the ability to modify those programs with respect
to DDI alerts, the use of technologies to assist in receiving, ﬁlling
and dispensing medication orders, and prescription volume. The
dependent variable in this study was the rate of dispensed med-
ications that may interact. RESULTS: A total of 672 pharmacies
were included in the analysis. On average (+/−SD), the respon-
dents ﬁlled 1375+/−691 prescriptions per week, submitted
17,948+/−23,889 pharmacy claims to the participating PBMs,
had 1.2+/−0.3 full-time equivalent (FTE) pharmacists per hour
open, and 545 (81%) were afﬁliated with a chain drug store
organization. Factors signiﬁcantly related to an increased risk of
dispensing a potential DDI included pharmacist workload (OR
1.03, 95% CI 1.028 to 1.048), pharmacy stafﬁng (OR 1.10,
95% CI: 1.09 to 1.11), and various technologies (e.g., sophisti-
cated telephone systems, internet receipt of orders and reﬁll
requests) that assist with order processing as well as the ability
to modify DDI alert screening sensitivity and detailed pharma-
cological information about DDIs. CONCLUSION: This study
found there was an increase in the risk of dispensing a potential
DDIs and higher pharmacist and pharmacy workload, and use
of dispensing automation systems.
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OBJECTIVES: To quantify and characterize economic-content
in pharmaceutical advertisements in leading medical journals
from 1990–2003, and to determine if economic ads declined 
in journals after enactment of Section 114 of the 1997 Food 
and Drug Administration Modernization Act (FDAMA).
METHODS: Two researchers reviewed all pharmaceutical
advertisements in three leading general medical (New England
Journal of Medicine, JAMA, and Annals of Internal Medicine)
and three specialty journals (Circulation, Gastroenterology, Neu-
rology) in three speciﬁed months each year for 2000 through
2003. Using a standardized data collection form, we investigated
economic claims (e.g., ads using the words “value”, “price”,
“savings”, “hospitalization”), as well as presence of supporting
evidence. This work builds upon our previous research of eco-
nomic claims from 1990–1999, using an identical methodology.
We hypothesized that economic promotion in journals declined
after 1997 FDAMA Section 114, because that law encouraged
such promotion in direct-to-managed care communications and
signaled the FDA’s growing vigilance over the area. RESULTS:
We reviewed 2144 pharmaceutical ads from 1990–1999 and 
779 from 2000–2003. Economic content occurred in 11.1% of
ads in the 1990s, and 7.6% of ads in 2000–2003 (p = 0.0058).
The frequency of economic ads peaked in 1997 at 16.2% and
declined thereafter (test for trend: p = 0.0017), reaching a low
of 6.3% in 2002. The presence of any supporting evidence for
economic claims was similar in the 1990s and early 2000s
